Medulloblastoma

• CLINICAL_TRIALS withdrawal · 2026-01-08
  Clinical Trial Update: Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies [Phase 1]

  A Phase 1 trial investigating fourth-ventricular administration of nivolumab with methotrexate or 5-azacytidine for recurrent medulloblastom…

• CLINICAL_TRIALS withdrawal · 2024-10-26
  Clinical Trial Update: Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer [Phase 1]

  A Phase 1 trial investigating chemotherapy and donor stem cell transplantation for high-grade brain cancers has been withdrawn. The study in…

• CLINICAL_TRIALS withdrawal · 2024-10-09
  Clinical Trial Update: StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord [Phase 1]

  Phase 1 trial evaluating StrataXRT to prevent radiation dermatitis in pediatric patients undergoing brain or spinal irradiation has been wit…

• CLINICAL_TRIALS withdrawal · 2017-08-25
  Clinical Trial Update: Dosimetry Guided PRRT With 90Y-DOTATOC [Phase 2]

  A Phase 2 trial evaluating dosimetry-guided peptide receptor radionuclide therapy using 90Y-DOTATOC has been withdrawn. The study covered ne…

• CLINICAL_TRIALS withdrawal · 2017-04-28
  Clinical Trial Update: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors [NA]

  A clinical trial evaluating 68Ga-DOTATOC PET-CT for brain tumors in children and young adults has been withdrawn from the study.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2015-05-22
  Clinical Trial Update: Valproic Acid in Childhood Progressive Brain Tumors [Phase 1]

  The trial withdrawal notice states that the Phase 1 study of valproic acid for childhood progressive brain tumors has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2013-08-27
  Clinical Trial Update: A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma [Phase 1]

  This Phase 1 trial of LY2940680 in pediatric medulloblastoma and rhabdomyosarcoma was withdrawn.